Scientists from King’s College London have announced that 16 human embryonic stem (hES) cell lines have been approved by the US National Institutes of Health (NIH) and placed on their Stem Cell Registry, making them freely available for federally-funded research in the USA. The stem cell lines, which carry genes for a variety of hereditary disorders such as Huntington’s disease, spinal muscular dystrophy and cystic fibrosis, are considered to be ideal research tools for designing models to understand disease progression, and ultimately in helping scientists develop new treatments for patients.
The development is a significant milestone for King’s and keeps the university at the forefront of global research into regenerative medicine.
Read the full, original story here: Disease-Specific Human Embryonic Stem Cell Lines Placed On NIH Registry
